Randomized Study of enterade(®) to Reduce Diarrhea in Patients Receiving High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation

High-dose chemotherapy frequently causes injury to the gastrointestinal mucosa, resulting in diarrhea. The purpose of the current study was to assess the tolerability and efficacy of enterade(®) in reducing ≥ grade 2 diarrhea (G2D) in association with high-dose melphalan followed by autologous stem...

Descripción completa

Detalles Bibliográficos
Autores principales: De Filipp, Zachariah, Glotzbecker, Brett, Luque, Laura, Kim, Haesook T, Mitchell, Katherine M, Cheuvront, Samuel N, Soiffer, Robert J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184175/
https://www.ncbi.nlm.nih.gov/pubmed/33507712
http://dx.doi.org/10.31557/APJCP.2021.22.1.301

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184175/
https://www.ncbi.nlm.nih.gov/pubmed/33507712
http://dx.doi.org/10.31557/APJCP.2021.22.1.301

Ejemplares similares